BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25339676)

  • 1. T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.
    Popescu I; Pipeling MR; Shah PD; Orens JB; McDyer JF
    J Immunol; 2014 Dec; 193(11):5709-5722. PubMed ID: 25339676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.
    Popescu I; Pipeling MR; Mannem H; Shah PD; Orens JB; Connors M; Migueles SA; McDyer JF
    J Immunol; 2016 Jan; 196(2):877-90. PubMed ID: 26663780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.
    Pipeling MR; John ER; Orens JB; Lechtzin N; McDyer JF
    J Infect Dis; 2011 Dec; 204(11):1663-71. PubMed ID: 22021622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
    Hassouneh F; Lopez-Sejas N; Campos C; Sanchez-Correa B; Tarazona R; Pera A; Solana R
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
    Pipeling MR; West EE; Osborne CM; Whitlock AB; Dropulic LK; Willett MH; Forman M; Valsamakis A; Orens JB; Moller DR; Lechtzin N; Migueles SA; Connors M; McDyer JF
    J Immunol; 2008 Jul; 181(1):546-56. PubMed ID: 18566421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.
    Shlobin OA; West EE; Lechtzin N; Miller SM; Borja M; Orens JB; Dropulic LK; McDyer JF
    J Immunol; 2006 Feb; 176(4):2625-34. PubMed ID: 16456025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
    J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.
    Bunde T; Kirchner A; Hoffmeister B; Habedank D; Hetzer R; Cherepnev G; Proesch S; Reinke P; Volk HD; Lehmkuhl H; Kern F
    J Exp Med; 2005 Apr; 201(7):1031-6. PubMed ID: 15795239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control.
    Akulian JA; Pipeling MR; John ER; Orens JB; Lechtzin N; McDyer JF
    Am J Transplant; 2013 Jan; 13(1):146-56. PubMed ID: 23016698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
    López-Oliva MO; Martinez V; Buitrago A; Jiménez C; Rivas B; Escuin F; Santana MJ; Selgas R; Bellón T
    Transplantation; 2014 Apr; 97(8):839-45. PubMed ID: 24345896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size.
    Chiu YL; Lin CH; Sung BY; Chuang YF; Schneck JP; Kern F; Pawelec G; Wang GC
    Sci Rep; 2016 Jan; 6():19227. PubMed ID: 26778409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
    Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells.
    Smith C; Elhassen D; Gras S; Wynn KK; Dasari V; Tellam J; Tey SK; Rehan S; Liu YC; Rossjohn J; Burrows SR; Khanna R
    Blood; 2012 Oct; 120(16):3237-45. PubMed ID: 22942184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
    Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D
    Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L; Sun Q; Lucas KG
    J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.
    Carbone J; Lanio N; Gallego A; Kern F; Navarro J; Muñoz P; Alonso R; Catalán P; Fernández-Yáñez J; Palomo J; Ruiz M; Fernández-Cruz E; Sarmiento E
    J Clin Immunol; 2012 Aug; 32(4):809-19. PubMed ID: 22371292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
    Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.